We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Progress Made Towards a Simple, Low-cost CRISPR-based SARS-CoV-2 Diagnostic

News   Mar 27, 2020 | Original story from the University of Connecticut

 
Progress Made Towards a Simple, Low-cost CRISPR-based SARS-CoV-2 Diagnostic

Credit: Pixabay

 
 
Advertisement
 

RELATED ARTICLES

Janssen COVID-19 Vaccine Issued Emergency Use Authorization by the FDA

News

The U.S. Food and Drug Administration issued an Emergency Use Authorization (EUA) to the Janssen Pharmaceuticals Companies of Johnson & Johnson for its single-shot COVID-19 vaccine, called Ad.26.COV2S or JNJ-78436725.

READ MORE

Confirmed Cases of Brazilian COVID-19 Variant in the UK

News

Up to 6 cases of the Variant of Concern first identified in Manaus, Brazil (P.1) have been detected in the UK. Public Health England (PHE) has identified 3 of these cases of the Variant of Concern in England.

READ MORE

Study of Over 20,000 Individuals Sheds Light on Genetic Contributions to Eating Disorders

News

By analysing the genome of tens of thousands of British people, researchers have discovered similarities between the genetic bases of various eating disorders, and those of other psychiatric disorders.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Genomics Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE